Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Jin Medical International Ltd. specializes in the manufacturing and distribution of medical instruments and supplies, primarily targeting the Chinese healthcare market. The company faces significant challenges due to declining revenues and margins, which are compounded by a competitive landscape characterized by rapid technological advancements.
Jin Medical generates revenue through the sale of medical instruments and supplies, leveraging its established distribution network in China. The company has limited pricing power due to competitive pressures and a focus on cost containment among healthcare providers.
Changes in healthcare regulations in China affecting procurement processes
Fluctuations in demand for medical supplies due to public health crises
Technological advancements in medical devices impacting product competitiveness
Market share shifts among key competitors
Technological disruption from advanced medical technologies that could render existing products obsolete
Regulatory changes in the healthcare sector that could impact product approvals and market access
Intense competition from both domestic and international medical supply companies
Emerging startups leveraging innovative technologies to capture market share
Moderate debt levels could constrain financial flexibility, especially during downturns
Low liquidity ratios may pose challenges in meeting short-term obligations
moderate - The healthcare sector is somewhat insulated from economic downturns, but reduced consumer spending can impact elective procedures and non-essential medical supplies.
Higher interest rates can increase financing costs for operational expansion and reduce capital investment in new technologies, negatively impacting growth prospects.
minimal - The company is not heavily reliant on credit for operations, though access to financing could affect growth initiatives.
value - Investors may be attracted to the stock due to its low valuation metrics despite operational challenges.
high - The stock has exhibited high volatility, particularly with a one-year return of -85%, indicating significant investor uncertainty.
